Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

MAYNF MAYNE PHARMA GROUP LIMITED

0.2030.0000.00%
Close 10/05 16:00 ET
High
0.000
Open
0.203
Turnover
0.00
Low
0.000
Pre Close
0.203
Volume
0.00
Market Cap
352.31M
P/E(TTM)
Loss
52wk High
0.293
Shares
1.74B
P/E(Static)
Loss
52wk Low
0.150
Float Cap
352.31M
Bid/Ask %
0.00%
Historical High
0.384
Shs Float
1.74B
Volume Ratio
0.00
Historical Low
0.150
Dividend TTM
--
Div Yield TTM
--
P/B
0.96
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.00%
Amplitude
0.00%
Avg Price
Lot Size
1
Float Cap
352.31M
Bid/Ask %
0.00%
Historical High
0.384
Shs Float
1.74B
Volume Ratio
0.00
Historical Low
0.150
Dividend TTM
--
P/B
0.96
Dividend LFY
--
Turnover Ratio
0.00%
Amplitude
0.00%
Avg Price
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Mayne Pharma Group Ltd. engages in the development and manufacture of proprietary and generic products. It operates through the following segments: Generic Products, Specialty Products, Metrics Contract Services, and Mayne Pharma International. The Generic Products segment is involved in the manufacture and distribution of generic and branded pharmaceutical products. The Metrics Contract Services segment provides contract pharmaceutical services. The Specialty Products segment includes the distribution of branded pharmaceutical products. The Mayne Pharma International segment manufactures and sells branded and generic pharmaceutical products and provides contract manufacturing services to third party customers within Australia. The company was founded in 1845 and is headquartered in Salisbury, Australia.
CEO: Mr. Scott Richards
Market: Pink Market
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...